(702) 683-8946

Monday - Friday 9am to 5pm

triangle
ad1

http://crweworld.com/assets/images/ad/content-delivery-solution.jpg

Our content delivery solution through CRWE WORLDCRWE Press Release and CRWE Tubegives corporations and businesses a vehicle to expand their exposure

Content Delivery Solution (Learn More)

ad3

https://crweworld.com/assets/img/crwe_info.png

CRWE Info ( CRWE.Info ) provides news and updates about Crown Equity Holdings Inc. and the CRWE World platform

www.crwe.info

ad4

https://crweworld.com/assets/images/ad/submit_a_press_release.jpg

Submit Your Press Release/News to the CRWE WORLD Network for $14.95! Increase Visibility, Boost Your Business

www.CRWEPressRelease.com






Latest News Releases From The Newsroom

Kosmos Energy Falls Short in Q2; Bullish View On Cigna and EchoStar

August 07th, 2023

Energy exploration and production company Kosmos Energy Ltd. (NYSE: KOS) announced its second-quarter 2023 financial results, reporting an earnings per share (EPS) of $0.05 and total revenues of $273.32 million. These figures fell short of the market. Read more

Earnings Preview: CyberArk, Veru, Affimed, and Credicorp in the Spotlight

August 06th, 2023

On Thursday, August 10, a lineup of companies is slated to present their financial performance, unveiling valuable insights into their recent activities and market dynamics. These companies include: CyberArk Software Ltd. (Nasdaq: CYBR), a leader . Read more

Key Metrics: Illumina, CleanSpark, MaxCyte, and Proterra's Earnings Preview

August 06th, 2023

A lineup of companies is poised to reveal their financial insights on Wednesday, August 9, shedding light on their recent performances and market trends. These companies include: Illumina, Inc. (Nasdaq: ILMN), a leader in genetic sequencing and an. Read more

A Preview: Datadog, Akamai, Lyft, and Clover Health Earnings Due

August 06th, 2023

On Tuesday, August 8, a lineup of companies is gearing up to unveil their financial performance, offering insights into their recent activities and market trends, including: Datadog, Inc. (Nasdaq: DDOG), a leader in monitoring and analytics soluti. Read more

Earnings Countdown: Zai Lab, Alteryx, Medifast, and Manitowoc in the Spotlight

August 06th, 2023

On Monday, August 7, a roster of companies is set to unveil their financial results, shedding light on their recent performance and market trends, including: Zai Lab Limited (Nasdaq: ZLAB), a prominent biopharmaceutical player, is scheduled to rep. Read more

Earnings in Focus: P10, Zymeworks, Gevo, and WalkMe Gear Up

August 06th, 2023

A lineup of companies is gearing up to unveil their financial performance on Thursday, August 10, providing valuable insights into their recent activities and market dynamics, including: P10, Inc. (NYSE: PX), a versatile company, is scheduled to r. Read more

Earnings On Deck: Walt Disney, Plug Power, Genpact, and Inovio

August 06th, 2023

An array of companies is poised to present their financial outcomes on Wednesday, August 9, showcasing valuable insights into their recent performance and market dynamics. Among them are: The Walt Disney Company (NYSE: DIS), a global entertainment. Read more

Countdown to Earnings: Zoetis, TransDigm, Rivian, and AMC

August 05th, 2023

Some of the companies expected to report financial results on Tuesday, August 8, are: Zoetis Inc. (NYSE: ZTS), a frontrunner in animal health solutions, is set to announce its financial results before the opening of the market.  Analysts a. Read more

KKR, Palantir, ONEOK, and Celanese's Earnings On The Horizon: A Preview

August 05th, 2023

As the financial reporting season heats up, a number of companies are poised to reveal their second-quarter 2023 results, offering insights into their performance and market trends. The lineup for Monday, August 7, includes: KKR & Co. Inc. (NYSE: . Read more

Biogen-Sage's Zuranolone: FDA Says 'Yes' for PPD, 'No' for MDD

August 05th, 2023

Biogen Inc. (Nasdaq: BIIB) and Sage Therapeutics, Inc. (Nasdaq: SAGE) have received U.S. Food and Drug Administration (FDA) approval for ZURZUVAE (zuranolone) 50 mg, offering a groundbreaking 14-day oral treatment for postpartum depression (PPD) in a. Read more